Plan Group Financial LLC Has $258,000 Stock Position in Humana Inc. (NYSE:HUM)

Plan Group Financial LLC grew its position in Humana Inc. (NYSE:HUM) by 8.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 1,018 shares of the insurance provider’s stock after acquiring an additional 83 shares during the quarter. Plan Group Financial LLC’s holdings in Humana were worth $258,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HUM. State Street Corp raised its position in Humana by 1.0% during the third quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock valued at $1,701,582,000 after acquiring an additional 53,272 shares in the last quarter. FMR LLC raised its holdings in shares of Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after purchasing an additional 643,291 shares in the last quarter. Pzena Investment Management LLC raised its holdings in shares of Humana by 8.1% during the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after purchasing an additional 187,903 shares in the last quarter. Ontario Teachers Pension Plan Board lifted its stake in shares of Humana by 6.5% in the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after purchasing an additional 71,910 shares during the last quarter. Finally, Sanders Capital LLC boosted its holdings in Humana by 1.0% in the third quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider’s stock worth $370,060,000 after purchasing an additional 11,923 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Price Performance

Shares of NYSE:HUM opened at $257.24 on Wednesday. The firm has a market capitalization of $30.97 billion, a PE ratio of 25.85, a PEG ratio of 1.91 and a beta of 0.56. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The business’s 50 day moving average is $270.05 and its 200-day moving average is $291.47.

Humana (NYSE:HUM) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts predict that Humana Inc. will post 16.49 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have weighed in on HUM. Piper Sandler raised their target price on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and raised their price objective for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. JPMorgan Chase & Co. reduced their target price on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday. Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 price target on shares of Humana in a research report on Wednesday, February 12th. Finally, Truist Financial boosted their price objective on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Nineteen research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $285.68.

Insider Activity at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.29% of the stock is currently owned by insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.